Login / Signup
Clinical relevance of serum immunoglobulin G4 in glucocorticoid therapy of Graves' ophthalmopathy.
Yaling Li
Ban Luo
Jing Zhang
Xinrong Zhou
Shiying Shao
Weijie Xu
Yan Yang
Gang Yuan
Published in:
Clinical endocrinology (2021)
Our results suggest a possible subgroup of elevated IgG4 GO patients, with more severe ophthalmopathy and better response to GCs treatment compare with normal IgG4 GO patients.
Keyphrases
</>
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
clinical trial
bone marrow
cell therapy